The cholangiopathies: Disorders of biliary epithelia

Gastroenterology

Volumn 127, Issue 5, 2004, Pages 1565-1577

  Lazaridis, Konstantinos N ^a   Strazzabosco, Mario ^b,c   Larusso, Nicholas F ^a,d  

^a DEPARTMENT OF UROLOGY   (United States)

^b OSPEDALI RIUNITI   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; BILE DUCT; BILE DUCT DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; EPITHELIUM; HEPATOBILIARY SYSTEM; HUMAN; PATHOGENESIS; PHENOTYPE; PORTAL VEIN BLOOD; PRIORITY JOURNAL; REVIEW;

EID: 7644234675     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.08.006     Document Type: Article

References (102)

1. J.L. Boyer Bile duct epithelium frontiers in transport physiology Am J Physiol 270 1996 G1 G5
2. A.I. Masyuk, R.A. Marinelli, N.F. LaRusso Water transport by epithelia of the digestive tract Gastroenterology 122 2002 545 562
3. M. Strazzabosco, C. Spirlì, L. Okolicsanyi Pathophysiology of the intrahepatic biliary epithelium J Gastroenterol Hepatol 15 2000 244 253
4. M. Strazzabosco Transport systems in cholangiocytes their role in bile formation and cholestasis Yale J Biol Med 70 1997 427 434
5. M. Strazzabosco New insights into cholangiocyte physiology J Hepatol 27 1997 945 952
6. M. Marzioni, S.S. Glaser, H. Francis, J.L. Phinizy, G. LeSage, G. Alpini Functional heterogeneity of cholangiocytes Semin Liver Dis 22 2002 227 240
7. N. Kanno, G. LeSage, S. Glaser, D. Alvaro, G. Alpini Functional heterogeneity of the intrahepatic biliary epithelium Hepatology 31 2000 555 561
8. G. LeSage, S. Glaser, G. Alpini Regulation of cholangiocyte proliferation Liver 21 2001 73 80
9. G. Alpini, J.M. McGill, N.F. LaRusso The pathobiology of biliary epithelia Hepatology 35 2002 1256 1268
10. D. Alvaro, A. Gigliozzi, A.F. Attili Regulation and deregulation of cholangiocyte proliferation J Hepatol 33 2000 333 340
11. D. Alvaro, G. Alpini, P. Onori, A. Franchitto, S.S. Glaser, G. Le Sage, F. Folli, A.F. Attili, E. Gaudio Alfa and beta estrogen receptors and the biliary tree Mol Cell Endocrinol 193 2002 105 108
12. D. Alvaro, G. Alpini, P. Onori, L. Perego, G. Svegliati Baroni, A. Franchitto, S.S. Glaser, G. Le Sage, F. Folli, E. Gaudio Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats Gastroenterology 119 2000 1681 1691
13. T. Ezure, T. Sakamoto, H. Tsuji, J.G. Lunz III, N. Murase, J.J. Fung, A.J. Demetris The development and compensation of biliary cirrhosis in interleukin-6-deficient mice Am J Pathol 156 2000 1627 1639
14. R. Joplin, T. Hishida, H. Tsubouchi, Y. Daikuhara, R. Ayres, J. Neuberger, A.J. Strain Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor J Clin Invest 90 1992 1284 1289
15. G. Alpini, S. Glaser, D. Alvaro, Y. Ueno, M. Marzioni, H. Francis, L. Baiocchi, T. Stati, B. Barbaro, J.L. Phinizy, J. Mauldin, G. LeSage Bile acid depletion and repletion regulated cholantiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats Gastroenterology 123 2002 1226 1237
16. T.V. Masyuk, E.L. Ritman, N.F. LaRusso Hepatic artery and portal vein remodeling in rat liver. Vascular response to selective cholangiocyte proliferation Am J Pathol 162 2003 1175 1182
17. A. Celli, F.G. Que Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma Semin Liver Dis 18 1998 177 185
18. A. Celli, F.G. Que, G.J. Gores, N.F. LaRusso Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes Am J Physiol 275 1998 G749 G757
19. W. Faubion, M.E. Guicciardi, H. Miyoshi, S.F. Bronk, P.J. Roberts, P.A. Svingen, S.H. Kaufmann, G.J. Gores Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas J Clin Invest 103 1999 137 145
20. D.H. Adams, S.C. Afford The role of cholangiocytes in the development of chronic inflammatory liver disease Front Biosci 7 2002 e276 e285
21. J. Gozlan, I. Nion, O. Chazouilleres, Y. Chretien, R. Poupon Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activity Am J Gastroenterol 95 2000 3328 3329
22. S.C. Afford, J. Ahmed-Choudhury, S. Randhawa, C. Russell, J. Youster, H.A. Crosby, A. Eliopoulos, S.G. Hubscher, L.S. Young, D.H. Adams CD40 activation-induced, Fas-dependent apoptosis and NF-κB/AP-1 signaling in human intrahepatic biliary epithelial cells FASEB J 15 2001 2345 2354
23. S. Fiorucci, A. Mencarelli, B. Palazzetti, P. Del Soldato, A. Morelli, I.J. Ignarro An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibited caspase activity Proc Natl Acad Sci U S A 98 2001 2652 2657
24. S. Cory, J.M. Adams The Bcl-2 family regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656
25. J. Park, L. Tadlock, G.J. Gores, T. Patel Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line Hepatology 30 1999 1128 1133
26. C. Spirli, M.H. Nathanson, R. Fiorotto, E. Duner, L.A. Denson, J.M. Sanz, F. Di Virgilio, L. Okolicsanyi, F. Casagrande, M. Strazzabosco Pro-inflammatory cytokines inhibit secretion in rat bile duct epithelium Gastroenterology 121 2001 156 169
27. C. Spirli, L. Fabris, E. Duner, R. Fiorotto, G. Ballardini, T. Roskams, N.F. LaRusso, A. Sonzogni, L. Okolicsanyi, M. Strazzabosco Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes Gastroenterology 124 2003 737 753
28. F. Marra Chemokines in liver inflammation and fibrosis Front Biosci 1 2002 d1899 d1914
29. M. Jaiswal, N.F. LaRusso, G.J. Gores Nitric oxide in gastrointestinal epithelial cell carcinogenesis linking inflammation to oncogenesis Am J Physiol Gastrointest Liver Physiol 281 2001 G626 G634
30. M. Neuman, P. Angulo, I. Malkiewicz, R. Jorgensen, N. Shear, E.R. Dickson, J. Haber, G. Katz, K. Lindor Tumor necrosis factor-α and transforming growth factor-β reflect severity of liver damage in primary biliary cirrhosis J Gastroenterol Hepatol 17 2002 196 202
31. O.M. Martinez, J.C. Villanueva, M.E. Gershwin, S.M. Krams Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis Hepatology 21 1995 113 119
32. R.C. Ayres, J.M. Neuberger, J. Shaw, R. Joplin, D.H. Adams Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells effect of pro-inflammatory cytokines Gut 34 1993 1245 1249
33. Z. Liu, T. Sakamoto, T. Ezure, S. Yokomuro, N. Murase, G. Michalopoulos, A.J. Demetris Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice interactions between the periductal inflammatory and stromal cells and the biliary epithelium Hepatology 28 1998 1260 1268
34. L. Fabris, M. Strazzabosco, H.A. Crosby, G. Ballardini, S.G. Hubscher, D.A. Kelly, J.M. Neuberger, A.J. Strain, R. Joplin Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations Am J Pathol 156 2000 1599 1612
35. D.C. Rockey, L. Fouassier, J.J. Chung, A. Carayon, P. Vallee, C. Rey, C. Housset Cellular localization of endothelin-1 and increased production in liver injury in the rat potential for autocrine and paracrine effects on stellate cells Hepatology 27 1998 472 480
36. V.J. Desmet Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities Mayo Clin Proc 73 1998 80 89
37. T. Roskams Progenitor cell involvement in cirrhotic human liver diseases from controversy to consensus J Hepatol 39 2003 431 434
38. A.R. Crawford, L. Xi-Zhang, J.M. Crawford The normal adult human liver biopsy a quantitative reference standard Hepatology 28 1998 323 331
39. N.D. Theise, R. Saxena, B.C. Portmann, S.N. Thung, H. Yee, L. Chiriboga, A. Kumar, J.M. Crawford The canals of Hering and hepatic stem cells in humans Hepatology 30 1999 1425 1433
40. T. Roskams, S. Yang, A. Koteish, A. Durnez, R. De Vos, X. Huang, R. Achten, C. Verslype, A.M. Diehl Oxidative stress and progenitor accumulation in mice and humans with alcoholic and non-alcoholic fatty liver diseases Am J Pathol 163 2003 1301 1311
41. L. Libbrecht, V. Desment, B. Van Damme, T. Roskams Deep intralobular extension of human hepatic progenitor cells correlates with parenchymal inflammation in chronic viral hepatitis can progenitor cells migrate? J Pathol 192 2000 373 378
42. + exchanger activities in primary biliary cirrhosis Hepatology 35 2002 1513 1521
43. C. Grappone, M. Pinzani, M. Parola, G. Pellegrini, A. Caligiuri, R. DeFranco, F. Marra, H. Herbst, G. Alpini, S. Milani Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats J Hepatol 31 1999 100 109
44. P.C. de Groen, G.J. Gores, N.F. LaRusso, L.L. Gunderson, D.M. Nagorney Biliary tract cancers N Engl J Med 341 1999 1368 1378
45. K.A. Fleming, K.M. Boberg, H. Glaumann, A. Bergquist, D. Smith, O.P.F. Clausen Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 34 2001 360 365
46. T. Shimonishi, M. Sasaki, Y. Nakanuma Precancerous lesions of intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 7 2000 542 550
47. M. Jaiswal, N.F. LaRusso, R.A. Shapiro, T.R. Billiar, G.J. Gores Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes Gastroenterology 120 2001 190 199
48. M. Jaiswal, N.F. LaRusso, N. Nishioka, Y. Nakabeppu, G.J. Gores Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide Cancer Res 61 2001 6388 6393
49. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, N. Schiavone, A. Vannacci, S. Nistri, I. Sardi, G. Baroni, C. Marzocca, F. Perna, R. Mazzanti, P. Bechi, E. Masini Inducible nitric oxide synthase expression in human colorectal cancer correlation with tumor angiogenesis Am J Pathol 162 2003 793 801
50. W. Xu, L.Z. Liu, M. Loizidou, M. Ahmed, I.G. Charles The role of nitric oxide in cancer Cell Res 12 2002 311 320
51. G. Gores Cholangiocarcinoma current concepts and insights Hepatology 37 2003 961 969
52. T. Wu, J. Leng, C. Han, A.J. Demetris The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells Mol Cancer Ther 3 2004 299 307
53. Y. Nakanuma, K. Harada, A. Ishikawa, Y. Zen, M. Sasaki Anatomic and molecular pathology of intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 2003 265 281
54. C. Marienfeld, L. Tadlock, Y. Yamagiwa, T. Patel Inhibition of cholangiocarcinoma growth by tannic acid Hepatology 37 2003 1097 1104
55. S. Yokomuro, H. Tsuji, J.G. Lunz III, T. Sakamoto, T. Ezure, N. Murase, A.J. Demetris Growth control of biliary epithelial cells by interleukin-6, hepatocyte growth factor, transforming growth factor-β and activin A comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells Hepatology 32 2000 26 35
56. 2+, PKC- and MAPK-dependent pathways Am J Physiol Gastrointest Liver Physiol 286 2004 G973 G982
57. X.M. Chen, S.A. Levine, P. Tietz, E. Krueger, M.A. McNiven, D.M. Jefferson, M. Mahle, N.F. LaRusso Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism Hepatology 28 1998 906 913
58. X.M. Chen, G.J. Gores, C.V. Paya, N.F. LaRusso Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism Am J Physiol 277 1999 G599 G608
59. X.M. Chen, N.F. LaRusso Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells Gastroenterology 118 2000 368 379
60. X.M. Chen, S.A. Levine, P.L. Splinter, P.S. Tietz, A.L. Ganong, C. Jobin, G.J. Gores, C.V. Paya, N.F. LaRusso Cryptosporidium parvum activates nuclear factor-κB in biliary epithelia preventing epithelial cell apoptosis Gastroenterology 120 2001 1774 1783
61. X.M. Chen, J.S. Keithly, C.V. Paya, N.F. LaRusso Cryptosporidiosis N Engl J Med 346 2002 1723 1731
62. L.D. Campbell, J.N. Stewart, J.R. Mead Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice J Parasitol 88 2002 1014 1016
63. G.A. Mathis, S.A. Walls, P. D'Amico, T.F. Gengo, A.E. Sirica Enzyme profile of rat bile ductular epithelial cells in reference to the resistance phenotype in hepatocarcinogenesis Hepatology 9 1989 477 485
64. F. Lakehal, D. Wendum, V. Barbu, L. Becquemont, R. Poupon, P. Balladur, L. Hannoun, F. Ballett, P.H. Beaune, C. Housset Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium Hepatology 30 1999 1498 1506
65. 4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism Am J Physiol Gastrointest Liver Physiol 284 2003 G290 G301
66. A. Gigliozzi, F. Fraioli, P. Sundaram, J. Lee, A. Mennone, D. Alvaro, J.L. Boyer Molecular identification and functional characterization of Mdr1a in rat cholangiocytes Gastroenterology 119 2000 1113 1122
67. K.N. Lazaridis, L. Pham, P. Tietz, R.A. Marinelli, P.C. deGroen, S. Levine, P.A. Dawson, N.F. LaRusso Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter J Clin Invest 100 1997 2714 2721
68. D.H. Perlmutter, R.W. Shepherd Extrahepatic biliary atresia a disease or a phenotype? Hepatology 36 2002 1297 1304
69. G. Alpini, S.S. Glaser, Y. Ueno, L. Pham, P.V. Podila, A. Caligiuri, G. LeSage, N.F. LaRusso Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation Am J Physiol 274 1998 G767 G775
70. E.A. Rodriguez-Garay Cholestasis human disease and experimental animal models Ann Hepatol 2 2003 150 158
71. F. Hirano, A. Kobayashi, Y. Hirano, Y. Nomura, E. Fukawa, I. Makino Bile acids regulate RANTES gene expression through its cognate NF-κB binding sites Biochem Biophys Res Commun 288 2001 1095 1101
72. L. Libbrecht, D. Cassiman, V. Desmet, T. Roskams Expression of neutral cell adhesion molecule in human liver development and in congenital and acquired liver diseases Histochem Cell Biol 116 2001 233 239
73. J. Hughes, C.J. Ward, B. Peral, R. Aspinwall, K. Clark, J.L. San Millan, V. Gamble, P.C. Harris The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains Nat Genet 10 1995 151 160
74. T. Mochizuki, G. Wu, T. Hayashi, S.L. Xenophontos, B. Veldhuisen, J.J. Saris, D.M. Reynolds, Y. Cai, P.A. Gabow, A. Pierides, W.J. Kimberling, M.H. Breuning, C.C. Deltas, D.J. Peters, S. Somlo PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein Science 272 1996 1339 1342
75. C.J. Ward, M.C. Hogan, S. Rossetti, D. Walker, T. Sneddon, X. Wang, V. Kubly, J.M. Cunningham, R. Bacallao, M. Ishibashi, D.S. Milliner, V.E. Torres, P.C. Harris The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein Nat Genet 30 2002 259 269
76. A.I. Masyuk, T.V. Masyuk, P.L. Splinter, B.Q. Huang, N.F. LaRusso Cholangiocytes contain primary cilia that function as sensory organelles potential role in ductal bile formation Hepatology 38 2003 107A
77. T.V. Masyuk, B.Q. Huang, C.J. Ward, A.I. Masyuk, D. Yuan, P. Splinter, R. Punyashthiti, E.L. Ritman, V.E. Torres, P.C. Harris, N.F. LaRusso Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat Gastroenterology 125 2003 1303 1310
78. C.J. Ward, D. Yuan, T.V. Masyuk, X. Wang, R. Punyashthiti, S. Whelan, R. Bacallao, R. Torra, N.F. LaRusso, V.E. Torres, P.C. Harris Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia Hum Mol Genet 12 2003 2703 2710
79. J.P. Drenth, R.H. te Morsche, R. Smink, J.S. Bonifacino, J.B. Jansen Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease Nat Genet 33 2003 345 347
80. J.A. Cohn, T.V. Strong, M.R. Picciotto, A.C. Nairn, F.S. Collins, J.G. Fitz Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells Gastroenterology 105 1993 1857 1864
81. - Nat Med 7 2001 292 293
82. A. Zsembery, W. Jessner, G. Sitter, C. Spirli, M. Strazzabosco, J. Graf The wide spectrum of MDR-3 deficiency from neonatal cholestasis to cirrhosis of adulthood Gastroenterology 120 2001 1448 1458 Correction of Jacquemin E, De Vree JM, Creteil D, Sokal EM,Sturm E, Dumont M, et al.
83. E. Jacquemin, J.M. De Vree, D. Cresteil, E.M. Sokal, E. Sturm, M. Dumont, G.L. Scheffer, M. Paul, M. Burdelski, P.J. Bosma, O. Bernard, M. Hadchowel, R.P. Elferink The wide spectrum of MDR-3 deficiency from neonatal cholestasis to cirrhosis of adulthood Gastroenterology 120 2001 1448 1458
84. A. Hofmann Bile acid secretion, bile flow and biliary lipid secretion in humans Hepatology 12 1990 S17 S22
85. P. Fickert, G. Zollner, A. Fuchsbichler, C. Stumptner, A.H. Weiglein, F. Lammert, H.U. Marschall, O. Tsybrovskyy, K. Zatloukal, H. Denk, M. Trauner Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and mdr-2 knockout mice via disruption of cholangioles Gastroenterology 123 2002 1238 1251
86. P. Fickert, A. Fuchsbichler, M. Wagner, G. Zollner, A. Kaser Tilg H., R. Krause, F. Lammert, C. Langner, K. Zatloukal, H.U. Marschall, H. Denk, M. Trauner Regurgitation of bile acid from leaky bile ducts causes sclerosing cholangitis in mdr-2 (Abcb4) knockout mice Gastroenterology 127 2004 261 274
87. M.M. Kaplan Primary biliary cirrhosis past, present, and future Gastroenterology 123 2002 1392 1394
88. J.M. Palmer, J.A. Kirby, D.E. Jones The immunology of primary biliary cirrhosis the end of the beginning? Clin Exp Immunol 129 2002 191 197
89. J. Neuberger Antibodies and primary biliary cirrhosis--piecing together the jigsaw J Hepatol 36 2002 126 129
90. D.H. Adams Biliary epithelial cells innocent victims or active participants in immune-mediated liver disease? J Lab Clin Med 128 1996 528 530
91. C. Selmi, D.L. Balkwill, P. Invernizzi, A.A. Ansari, R.L. Coppel, M. Podda, P.S. Leung, T.P. Kenny, J. Van der Water, M.H. Nantz, M.J. Kurth, M.E. Gershwin Patients with primary biliary cirrhosis react against a ubiquituus xenobiotic-metabolizing bacterium Hepatology 38 2003 1250 1257
92. L. Xu, Z. Shen, L. Gao, B. Fodera, A. Keogh, R. Joplin, B. O'Donnell, J. Aitken, W. Carman, J. Neuberger, A. Mason Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 100 2003 8454 8459
93. H. Kita, X.S. He, M.E. Gershwin Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis Ann Med 36 2004 72 80
94. K. Amano, P.S. Leung, Q. Xu, J. Marik, C. Quan, M.J. Kurth, M.H. Nantz, A.A. Ansari, K.S. Lam, M. Zeniya, R.L. Coppel, M.E. Gershwin Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible J Immunol 172 2004 6444 6452
95. S.F. Bruggraber, P.S. Leung, K. Amano, C. Quan, M.J. Kurth, M.H. Nantz, G.D. Benson, J. Van de Water, V. Luketic, T.E. Roche, A.A. Ansari, R.L. Coppel, M.E. Gershwin Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis Gastroenterology 125 2003 1705 1713
96. S.A. Long, J. Van de Water, M.E. Gershwin Antimitochondrial antibodies in primary biliary cirrhosis the role of xenobiotics Autoimmun Rev 1 2002 37 42
97. S.P. Fussey, J.R. Guest, O.F. James, M.F. Bassendine, S.J. Yeaman Identification and analysis of the major M autoantigens in primary biliary cirrhosis Proc Natl Acad Sci U S A 85 1998 8654 8658
98. S.J. Yeaman, S.P. Fussey, D.J. Danner, O.F. James, D.J. Mutimer, M.F. Bassendine Primary biliary cirrhosis identification of two major M2 mitochondrial autoantigens Lancet 1 85924 1988 1067 1070
99. R. Joplin, J.G. Lindsay, G.D. Johnson, A. Strain, J. Neuberger Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis Lancet 339 1992 93 94
100. C. Migliaccio, J. Van de Water, A.A. Ansari, M.M. Kaplan, R.L. Coppel, K.S. Lam, R.K. Thompson, F. Stevenson, M.E. Gershwin Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2 the molecule versus the mimic Hepatology 33 2001 792 801
101. N. Fukushima, G. Nalbandian, J. Van de Water, K. White, A.A. Ansari, P. Leung, T. Kenny, S.G. Kamita, B.D. Hammock, R.L. Coppel, F. Stevenson, H. Ishibashi, M.E. Gershwin Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC Hepatology 36 2002 1383 1392
102. S. Matsumura, J. Van de Water, P. Leung, J.A. Odin, K. Yamamoto, G.J. Gores, K. Mostov, A.A. Ansari, R.L. Coppel, Y. Shiratori, M.E. Gershwin Caspase induction by IgA antimitochondrial antibody IgA-mediated biliary injury in primary biliary cirrhosis Hepatology 39 2004 1415 1422